| LLY | Eli Lilly and Co | 7.77% |
| ABBV | AbbVie Inc | 7.39% |
| MRK | Merck & Co Inc | 7.07% |
| JNJ | Johnson & Johnson | 6.96% |
| BMY | Bristol-Myers Squibb Co | 6.29% |
| BIIB | Biogen Inc | 3.84% |
| VTRS | Viatris Inc | 3.62% |
| CAH | Cardinal Health Inc | 3.53% |
| VRTX | Vertex Pharmaceuticals Inc | 3.41% |
| AMGN | Amgen Inc | 3.18% |
The First Trust Nasdaq Pharmaceuticals ETF is an exchange-traded fund. The investment objective of the Fund is to seek investment results that correspond generally to the price and yield, before the Fund's fees and expenses, of an index called the Nasdaq US Smart Pharmaceuticals Index. The Fund seeks to replicate the holdings and weightings of the Nasdaq US Smart Pharmaceuticals Index so as to generate performance results 95% correlated to that of the Nasdaq US Smart Pharmaceuticals Index.
First Trust Nasdaq Pharmaceuticals ETF · Issued by First Trust
No recent news for FTXH. The ingest cron pulls every 15 minutes during market hours.